Tests spinal fluid proteins to predict multiple sclerosis outlook
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study checks specific proteins in spinal fluid to see whether they can predict how multiple sclerosis (or related symptoms like optic neuritis) may go over time. It may help doctors better estimate prognosis using results from tests you may already be having.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have multiple sclerosis or optic neuritis (a condition that can be part of the early MS spectrum)
- You must be able to have a lumbar puncture (spinal tap) as part of routine testing
- You must also have a brain MRI as part of routine testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a protein called FCRL5 in your blood to see if it is linked to multiple sclerosis and how well treatments work. It also includes people with Sjögren's syndrome and healthy volunteers for comparison. You may be asked to give blood samples and answer some questions.
This study measures blood markers (from a serum blood sample) to see how nerve and brain changes relate to MS disease activity and disability over time. It may help researchers better monitor MS, especially in people followed in the OFSEP program.
This study looks at different immune cells in blood and, sometimes, spinal fluid (CSF) to understand what’s driving multiple sclerosis (MS) or early MS-like symptoms. Your participation may help researchers better explain the disease and potentially improve how it’s diagnosed or treated.
This study looks at a protein called kappa free light chains (KFLC) in the spinal fluid and blood of people with multiple sclerosis (MS) or a first MS-like episode (CIS). The goal is to better understand how this protein relates to the disease, which may help with diagnosis and monitoring.
This study looks at people who are at higher risk for multiple sclerosis (MS), to better understand early changes before MS is diagnosed. It may help doctors identify who is more likely to develop MS and how to monitor them sooner.
This study measures specific proteins in your blood that may help doctors understand how progressive multiple sclerosis advances. By tracking these markers over time, researchers hope to better predict disease progression and improve treatment decisions.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.